{"alanine aminotransferase increased": 4.16, "amylase increased": 7.25, "anaemia": 2.64, "ascites": 4.3, "aspartate aminotransferase increased": 4.14, "blast crisis in myelogenous leukaemia": 108.32, "blood alkaline phosphatase increased": 3.45, "blood bilirubin increased": 6.43, "blood creatine phosphokinase increased": 3.98, "blood creatinine increased": 2.94, "blood lactate dehydrogenase increased": 8.71, "blood urea increased": 4.92, "c-reactive protein increased": 2.06, "cardiac failure": 3.68, "chronic myeloid leukaemia": 72.79, "cytogenetic analysis abnormal": 113.4, "cytopenia": 5.01, "drug interaction": 5.99, "drug intolerance": 6.68, "drug level increased": 8.02, "drug resistance": 12.55, "electrocardiogram qt prolonged": 3.27, "eyelid oedema": 9.11, "face oedema": 5.62, "fluid retention": 4.65, "gamma-glutamyltransferase increased": 3.44, "gastrointestinal stromal tumour": 247.17, "generalised oedema": 13.06, "haemoglobin decreased": 3.51, "hepatic cytolysis": 5.21, "hepatic function abnormal": 2.82, "interstitial lung disease": 3.94, "jaundice": 2.14, "leukopenia": 2.76, "liver disorder": 4.37, "malignant neoplasm progression": 9.63, "metastases to liver": 14.56, "metastases to peritoneum": 28.95, "neoplasm progression": 2.89, "neoplasm recurrence": 52.37, "oedema": 9.82, "oedema peripheral": 4.04, "pancytopenia": 7.73, "pericardial effusion": 3.07, "periorbital oedema": 13.66, "platelet count decreased": 4.49, "pleural effusion": 9.46, "rash": 2.14, "renal impairment": 2.17, "second primary malignancy": 18.68, "skin exfoliation": 2.78, "subdural haematoma": 6.05, "therapeutic response decreased": 6.1, "therapy non-responder": 3.17, "thrombocytopenia": 2.44, "transaminases increased": 2.91, "treatment failure": 2.29, "white blood cell count decreased": 4.14, "white blood cell count increased": 9.0}